85 related articles for article (PubMed ID: 16105657)
21. DDX5 is a multifunctional co-activator of steroid hormone receptors.
Wagner M; Rid R; Maier CJ; Maier RH; Laimer M; Hintner H; Bauer JW; Onder K
Mol Cell Endocrinol; 2012 Sep; 361(1-2):80-91. PubMed ID: 22476084
[TBL] [Abstract][Full Text] [Related]
22. ERC-55, a binding protein for the papilloma virus E6 oncoprotein, specifically interacts with vitamin D receptor among nuclear receptors.
Imai T; Matsuda K; Shimojima T; Hashimoto T; Masuhiro Y; Kitamoto T; Sugita A; Suzuki K; Matsumoto H; Masushige S; Nogi Y; Muramatsu M; Handa H; Kato S
Biochem Biophys Res Commun; 1997 Apr; 233(3):765-9. PubMed ID: 9168930
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity.
Scimè A; Li L; Ciavarra G; Whyte P
J Cell Physiol; 2008 Mar; 214(3):568-81. PubMed ID: 17894419
[TBL] [Abstract][Full Text] [Related]
24. Identification of cyclin D3 as a direct target of E2A using DamID.
Song S; Cooperman J; Letting DL; Blobel GA; Choi JK
Mol Cell Biol; 2004 Oct; 24(19):8790-802. PubMed ID: 15367695
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis.
Rojas P; Cadenas MB; Lin PC; Benavides F; Conti CJ; Rodriguez-Puebla ML
Oncogene; 2007 Mar; 26(12):1723-30. PubMed ID: 16983339
[TBL] [Abstract][Full Text] [Related]
26. Thyroid hormone receptor-beta (TR beta 1) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2.
Porlan E; Vidaurre OG; Rodríguez-Peña A
Oncogene; 2008 Apr; 27(19):2795-800. PubMed ID: 18037966
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase 5 represses the transcription of cyclin D3.
Roy S; Shor AC; Bagui TK; Seto E; Pledger WJ
J Cell Biochem; 2008 Aug; 104(6):2143-54. PubMed ID: 18404677
[TBL] [Abstract][Full Text] [Related]
28. A role of helix 12 of the vitamin D receptor in SMRT corepressor interaction.
Kim JY; Son YL; Lee YC
Biochem Biophys Res Commun; 2009 Feb; 379(3):780-4. PubMed ID: 19133230
[TBL] [Abstract][Full Text] [Related]
29. Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation.
Maruyama R; Aoki F; Toyota M; Sasaki Y; Akashi H; Mita H; Suzuki H; Akino K; Ohe-Toyota M; Maruyama Y; Tatsumi H; Imai K; Shinomura Y; Tokino T
Cancer Res; 2006 May; 66(9):4574-83. PubMed ID: 16651407
[TBL] [Abstract][Full Text] [Related]
30. Crucial roles of D-type cyclins in the early stage of adipocyte differentiation.
Hishida T; Naito K; Osada S; Nishizuka M; Imagawa M
Biochem Biophys Res Commun; 2008 May; 370(2):289-94. PubMed ID: 18374658
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
Kong J; Li YC
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E916-24. PubMed ID: 16368784
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D resistance.
Bouillon R; Verstuyf A; Mathieu C; Van Cromphaut S; Masuyama R; Dehaes P; Carmeliet G
Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):627-45. PubMed ID: 17161336
[TBL] [Abstract][Full Text] [Related]
33. Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons.
Taniura H; Ito M; Sanada N; Kuramoto N; Ohno Y; Nakamichi N; Yoneda Y
J Neurosci Res; 2006 May; 83(7):1179-89. PubMed ID: 16521124
[TBL] [Abstract][Full Text] [Related]
34. New insight into the structure and functions of the vitamin D receptor.
MacDonald PN; Dowd DR; Haussler MR
Semin Nephrol; 1994 Mar; 14(2):101-18. PubMed ID: 8177978
[TBL] [Abstract][Full Text] [Related]
35. P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation.
Casanovas O; Jaumot M; Paules AB; Agell N; Bachs O
Oncogene; 2004 Sep; 23(45):7537-44. PubMed ID: 15326477
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D3 expression in normal fetal, normal adult and neoplastic feline tissue.
Norris AJ; Griffey SM; Lucroy MD; Madewell BR
J Comp Pathol; 2005 May; 132(4):329-39. PubMed ID: 15893991
[TBL] [Abstract][Full Text] [Related]
37. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity.
Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S
Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405
[TBL] [Abstract][Full Text] [Related]
38. The hematopoietic transcription factor AML1 (RUNX1) is negatively regulated by the cell cycle protein cyclin D3.
Peterson LF; Boyapati A; Ranganathan V; Iwama A; Tenen DG; Tsai S; Zhang DE
Mol Cell Biol; 2005 Dec; 25(23):10205-19. PubMed ID: 16287839
[TBL] [Abstract][Full Text] [Related]
39. Two-dimensional alanine scanning mutational analysis of the interaction between the vitamin D receptor and its ligands: studies of A-ring modified 19-norvitamin D analogs.
Shimizu M; Yamamoto K; Mihori M; Iwasaki Y; Morizono D; Yamada S
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):75-81. PubMed ID: 15225750
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation.
Freedman LP
J Nutr; 1999 Feb; 129(2S Suppl):581S-586S. PubMed ID: 10064337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
